21 related articles for article (PubMed ID: 3368198)
1. Flow-cytometrically monitored chromatin in situ testing in the breast cell line H184A1N4.
Weiss H; Langen P; Nitschke U; Thun I
J Cancer Res Clin Oncol; 1994; 120(7):399-402. PubMed ID: 8188732
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.
Fabian CJ; Zalles C; Kamel S; Kimler BF; McKittrick R; Tranin AS; Zeiger S; Moore WP; Hassanein RS; Simon C
Breast Cancer Res Treat; 1994; 30(3):263-74. PubMed ID: 7981444
[TBL] [Abstract][Full Text] [Related]
3. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution.
Weiss H; Kunde D; Streller B
Arch Geschwulstforsch; 1986; 56(5):373-9. PubMed ID: 3021084
[TBL] [Abstract][Full Text] [Related]
4. Mitotic rate, DNA distribution, and chromatin in situ sensitivity to heparin in breast cancer.
Weiss H; Brasching HP; Bock A; Mauthner F; Peek U
Breast Cancer Res Treat; 1990 Jul; 16(1):41-50. PubMed ID: 2169927
[TBL] [Abstract][Full Text] [Related]
5. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
Enchev VG; Dobreva PV
Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
[TBL] [Abstract][Full Text] [Related]
6. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
8. Pathology and heredity of breast cancer in younger women.
Marcus JN; Watson P; Page DL; Lynch HT
J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
[TBL] [Abstract][Full Text] [Related]
9. DNA distributions in human normal, precancerous and cancerous breast tissue. II. Differences in heparin mediated changes in DNA distributions.
Weiss H; Kunde D; Streller B
Oncology; 1988; 45(3):214-23. PubMed ID: 3368198
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
